Identification of Mirna Signature and Key Genes in Colorectal Cancer Lymph Node Metastasis

Abstract

Background: miRNAs and mRNAs can serve as biomarkers for the diagnosis, prognosis and therapy of colorectal cancer (CRC), whose metastasis to lymph node is closely related to the poor prognosis. The current study aimed to identify the novel gene signatures in the lymph node metastasis of CRC.Methods: GSE56350, GSE70574 and GSE95109 were downloaded from the Gene Expression Omnibus (GEO) database and 569 colorectal cancer statistics were also downloaded from the The Cancer Genome Atlas (TCGA) database. Differentially expressed miRNAs (DE-miRNAs) were calculated by using R software. Besides, gene ontology and Enriched pathway analysis of target mRNAs were analyzed by using FunRich. Furthermore, the mRNA-miRNA network was constructed using Cytoscape software. Gene expression level was verified by GEO datasets and forty paired lymph node non-metastasis CRC tissues and lymph node metastatic CRC tissues obtained from patients with CRC using quantitative real-time PCR (qPCR) .Results: In total, five DE-miRNAs were selected, and 34 mRNAs were identified after filtering. Moreover, 2 key miRNAs and one gene were identified including hsa-miR-99a, has-miR-100 and heparan sulfate-glucosamine 3-sulfotransferase 2 (HS3ST2). The GEO datasets analysis and qPCR results showed the expression of key miRNA and genes were consistent with that in the bioinformatic analysis. A novel miRNA-mRNA network, hsa-miR-99a-HS3ST2-has-miR-100 was found in lymph node metastasis of CRC after expression analysis, prognostic prediction and experiments confirmation.Conclusions: In summary, the potential miRNAs and genes were found and a novel miRNA-mRNA network was established in CRC lymph node metastasis by systematic bioinformatic analysis and experiments validation, which may be used as potential biomarkers in the development of lymph node metastatic CRC.

MUC13‑miRNA‑4647 axis in colorectal cancer: Prospects to identifications of risk factors and clinical outcomes

“…In another recent study, clusters miR-17/92a-1, miR-106a/363, miR-106b/93/25 and miR-183/96/182 showed the strongest association with metastasis occurrence and poor patient survival (41). Similarly, Wang et al (42) observed that the miR-99a-HS3ST2-miR-100 axis, a novel miRNA-mRNA network, was associated with the presence of lymph node metastasis in CRC. Insights into the roles of miRNAs in cancer have established them as targets for novel therapeutic approaches.…”

Identification and verification of microRNA signature and key genes in the development of osteosarcoma with lung metastasis

“…It is a promising therapeutic research field to inhibit or replace microRNAs. [14] One study found that miRNA-424-5p regulated ferroptosis by targeting Acyl-CoA Synthetase Long Chain Family Member 4 in OC cells and indicated a potential therapeutic target for ovarian cancer. [15] Wu et al [16] found that the downregulated microRNA-1301-3p inhabited lung carcinoma cell proliferation and migration and has a strong negative correlation with Polymerase I and transcript release factor.…”